Aster DM Healthcare Ltd Stock Price Today (NSE: ASTERDM)
Fundamental Score
Aster DM Healthcare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Aster DM Healthcare Ltd share price today is ₹670.00, up +2.45% on NSE/BSE as of 30 March 2026. Aster DM Healthcare Ltd (ASTERDM) is a Large-cap company in the Hospital sector with a market capitalisation of ₹34.69K (Cr). The 52-week high for ASTERDM share price is ₹732.20 and the 52-week low is ₹450.00. At a P/E ratio of 94.51x, ASTERDM is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 8.26% and a debt-to-equity ratio of 0.46.
Aster DM Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Aster DM Healthcare Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Aster DM Healthcare Share Price: A ROCE-Focused Analysis
One unique insight into the hospital industry is its increasing reliance on operational efficiency to navigate rising costs and competitive pressures. This analysis focuses on the financial health of Aster DM Healthcare Ltd (NSE: ASTERDM), examining its Return on Capital Employed (ROCE) and valuation metrics. The current Aster DM Healthcare share price is ₹563.0499877929688. This analysis forms part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra.
Aster DM Healthcare trades at a Price-to-Earnings (PE) ratio of 94.51. This is a relatively high valuation, suggesting investor expectations of future growth. A key indicator for evaluating whether this growth is sustainable is the company's ROCE, currently at 10.68%. ROCE measures how efficiently a company generates profits from its capital employed. A higher ROCE typically signifies better profitability and capital management. However, in Aster DM Healthcare's case, the 10.68% ROCE needs to be carefully evaluated against the relatively high PE ratio.
The 10.68% ROCE contributes to the assessment of Aster DM Healthcare’s economic moat. While not exceptionally high, a consistent ROCE in this range indicates a certain level of operational efficiency and potentially some barriers to entry or competitive advantages, such as brand recognition or geographical presence. This contributes, in part, to the ability of the company to generate profits from its operations and re-invest them in the business. Furthermore, the long-term sustainability of Aster DM Healthcare’s competitive advantage is related to management's ability to improve that ROCE, compared to sector peers.
When comparing Aster DM Healthcare Ltd with peers like
Nephro Care India Limited, a key area of differentiation lies in management quality and operational execution. Evaluating these qualitative factors helps to determine if a high PE ratio is warranted. While this analysis avoids offering specific buy/sell recommendations, understanding the dynamics between valuation multiples like PE and efficiency metrics like ROCE provides a framework for assessing potential investment opportunities in the healthcare sector. The financial stability of the company plays a vital role in the future growth of the share price of Aster DM Healthcare Ltd.Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Aster DM Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ASTERDM across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Strong Interest Coverage (5.41x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹2417.08 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 45.04%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Risk Factors
6 factors identified
Below-Average Return on Equity (8.26%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 94.51x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Limited Growth History (-13.71% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-7.24% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-7.24% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
High Share Pledging Risk (40.66%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
Aster DM Healthcare Ltd Financial Statements
Comprehensive financial data for Aster DM Healthcare Ltd including income statement, balance sheet and cash flow
About ASTERDM (Aster DM Healthcare Ltd)
Aster DM Healthcare Ltd is a prominent healthcare provider weaving a tapestry of comprehensive medical services within the vibrant Indian landscape. They stand as a multi-faceted e...ntity, extending care through a network of strategically located hospitals, conveniently accessible clinics, and fully integrated in-house pharmacies within those facilities. Their commitment to holistic well-being is evident in their diverse offerings, striving to cater to a wide spectrum of patient needs. Beyond direct patient care, they extend their expertise through consultancy services, sharing knowledge and best practices to elevate the broader healthcare ecosystem. Within the walls of Aster DM Healthcare's hospitals and clinics, a dedication to cutting-edge medical technology and patient-centric care is palpable. The organization aims to foster an environment of healing and trust, focusing on providing not just treatment, but also comfort and support. Through their in-house pharmacies, they ensure seamless access to essential medications, promoting adherence and contributing to better patient outcomes. This integrated approach, uniting various healthcare elements, allows for coordinated and efficient delivery of care. Beyond the core functions of hospitals, clinics, and pharmacies, Aster DM Healthcare further diversifies its reach into retail pharmacy and optical outlets. These extensions of the brand serve to bring healthcare accessibility closer to the community, catering to routine needs and promoting preventative care. Established in 1987 and rooted in Bengaluru, India, Aster DM Healthcare stands as a seasoned player in the Indian healthcare sector, continuously evolving to meet the dynamic needs of its growing patient base.
Company Details
Key Leadership
Corporate Events
Latest News
ASTERDM Share Price: Frequently Asked Questions
What is the current share price of Aster DM Healthcare Ltd (ASTERDM)?
As of 30 Mar 2026, 12:02 pm IST, Aster DM Healthcare Ltd share price is ₹670.00. The ASTERDM stock has a market capitalisation of ₹34.69K (Cr) on NSE/BSE.
Is ASTERDM share price Overvalued or Undervalued?
ASTERDM share price is currently trading at a P/E ratio of 94.51x, compared to the industry average of 52.84x. Based on this relative valuation, the Aster DM Healthcare Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of ASTERDM share price?
The 52-week high of ASTERDM share price is ₹732.20 and the 52-week low is ₹450.00. These values are updated daily from NSE/BSE price data.
What factors affect the Aster DM Healthcare Ltd share price?
Key factors influencing ASTERDM share price include quarterly earnings growth (Sales Growth: 10.20%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Aster DM Healthcare Ltd a good stock for long-term investment?
Aster DM Healthcare Ltd shows a 5-year Profit Growth of -7.24% and an ROE of 8.26%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.46 before investing in ASTERDM shares.
How does Aster DM Healthcare Ltd compare with its industry peers?
Aster DM Healthcare Ltd competes with major peers in the Hospital. Investors should compare ASTERDM share price P/E of 94.51x and ROE of 8.26% against the industry averages to determine competitive standing.
What is the P/E ratio of ASTERDM and what does it mean?
ASTERDM share price has a P/E ratio of 94.51x compared to the industry average of 52.84x. Investors pay ₹95 for every ₹1 of annual earnings.
How is ASTERDM performing according to Bull Run's analysis?
ASTERDM has a Bull Run fundamental score of 15.4/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ASTERDM belong to?
ASTERDM operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Aster DM Healthcare Ltd share price.
What is Return on Equity (ROE) and why is it important for ASTERDM?
ASTERDM has an ROE of 8.26%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Aster DM Healthcare Ltd generates profits from shareholders capital.
How is ASTERDM debt-to-equity ratio and what does it indicate?
ASTERDM has a debt-to-equity ratio of 0.46, which indicates moderate leverage that should be monitored.
What is ASTERDM dividend yield and is it a good dividend stock?
ASTERDM offers a dividend yield of 0.75%, meaning you receive ₹0.75 annual dividend for every ₹100 invested in Aster DM Healthcare Ltd shares.
How has ASTERDM share price grown over the past 5 years?
ASTERDM has achieved 5-year growth rates of: Sales Growth -13.71%, Profit Growth -7.24%, and EPS Growth -7.24%.
What is the promoter holding in ASTERDM and why does it matter?
Promoters hold 40.39% of ASTERDM shares, with 40.66% pledged. High promoter holding often indicates strong management confidence in Aster DM Healthcare Ltd.
What is ASTERDM market capitalisation category?
ASTERDM has a market capitalisation of ₹34688 crores, placing it in the Large-cap category.
How volatile is ASTERDM stock?
ASTERDM has a beta of N/A. A beta > 1 suggests the Aster DM Healthcare Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ASTERDM operating profit margin trend?
ASTERDM has a 5-year average Operating Profit Margin (OPM) of 14.86%, indicating the company's operational efficiency.
How is ASTERDM quarterly performance?
Recent quarterly performance shows Aster DM Healthcare Ltd YoY Sales Growth of 10.20% and YoY Profit Growth of 13.83%.
What is the institutional holding pattern in ASTERDM?
ASTERDM has FII holding of 18.72% and DII holding of 26.32%. Significant institutional holding often suggests professional confidence in the Aster DM Healthcare Ltd stock.